Connecticut House Bill HB06872

Connecticut 2019 Regular Session

• Introduced: 1/30/19
• Refer: 1/30/19

Caption

An Act Concerning The Labeling Of Prescription Drug Containers Containing Opiates.

Impact

If enacted, HB 06872 would have significant implications for state laws related to pharmaceutical labeling and patient information. It would obligate manufacturers and pharmacies to adopt new labeling practices that include potent indicators of danger specific to opiate drugs. Such an amendment signifies a proactive step in public health policy aimed at improving patient comprehension of their prescribed medications, potentially leading to more responsible usage and decreased instances of misuse.

Summary

House Bill 06872 proposes amendments to existing general statutes to enforce a new labeling requirement on prescription drug containers containing opiates. Specifically, the bill mandates that a heroin rating be included on the labels of these containers. The goal of such a requirement is to better inform patients about the potency of the opiate drugs they are prescribed and to alert them to the possible negative consequences associated with their use. The bill seeks to address concerns regarding opioid overdoses and dependency by enhancing awareness among patients.

Contention

Despite its public health intentions, the bill may encounter opposition from pharmaceutical companies concerned about the implications of such labeling on their products. The introduction of a heroin rating could raise concerns regarding how it may affect perceptions of safety and efficacy related to legitimate medical use. Additionally, discussions surrounding practical enforcement of these labeling requirements and the potential impact on healthcare providers' prescribing practices may generate further debate among legislators and stakeholders.